The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia–reperfusion injury in mice
Open Access
- 1 January 2014
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 85 (1), 134-141
- https://doi.org/10.1038/ki.2013.357
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Pharmacological Induction of Heme Oxygenase-1 by a Triterpenoid Protects Neurons Against Ischemic InjuryStroke, 2012
- Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1American Journal of Physiology-Renal Physiology, 2011
- Transcriptional Regulation of Renal Cytoprotective Genes by Nrf2 and Its Potential Use as a Therapeutic Target to Mitigate Cisplatin-Induced NephrotoxicityJournal of Pharmacology and Experimental Therapeutics, 2010
- The Triterpenoid CDDO-Imidazolide Confers Potent Protection against Hyperoxic Acute Lung Injury in MiceAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated miceCarcinogenesis: Integrative Cancer Research, 2009
- CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genesToxicology and Applied Pharmacology, 2009
- Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in miceProceedings of the National Academy of Sciences, 2009
- Genetic or Pharmacologic Amplification of Nrf2 Signaling Inhibits Acute Inflammatory Liver Injury in MiceToxicological Sciences, 2008
- CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer–binding protein alphaBlood, 2007
- Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-ImidazolideBiochemical and Biophysical Research Communications, 2006